WO1995001798A1 - Improvements in the method and process of thalassotherapy - Google Patents
Improvements in the method and process of thalassotherapy Download PDFInfo
- Publication number
- WO1995001798A1 WO1995001798A1 PCT/IT1994/000104 IT9400104W WO9501798A1 WO 1995001798 A1 WO1995001798 A1 WO 1995001798A1 IT 9400104 W IT9400104 W IT 9400104W WO 9501798 A1 WO9501798 A1 WO 9501798A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thalassotherapy
- sea water
- thermal
- thermal bathing
- bathing pools
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 43
- 230000008569 process Effects 0.000 title claims abstract description 20
- 239000013535 sea water Substances 0.000 claims abstract description 28
- 238000003287 bathing Methods 0.000 claims abstract description 27
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 28
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 230000001225 therapeutic effect Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000009471 action Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000007170 pathology Effects 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 230000035606 childbirth Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/08—Mineral waters; Sea water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
- B09B3/40—Destroying solid waste or transforming solid waste into something useful or harmless involving thermal treatment, e.g. evaporation
- B09B3/45—Steam treatment, e.g. supercritical water gasification or oxidation
Definitions
- the present invention relates to improvements in the method and process of thalassotherapy, wherein the sea water, before being used in the therapeutic process, is previously treated both for altering its natural composition and for increasing its temperature.
- the improvements in the method and process of thalassotherapy according to the present invention comprises the step to preliminarily trait the sea water, in order to change its natural composition, before putting it into a plurality of thermal bathing pools on which the subject in therapy is suggested to plunge for a predetermined period of time, as function of the objectives to be pursued.
- the sea water is preliminary treated to substantially remove the sodium chloride, commonly known as "salt", from there and to transform the same sea water in magnesium chloride in solution.
- the magnesium chloride in solution is normally obtained as residual liquid compound from the salt-works, in the production of salt starting from the sea water and till now has been substantially used solely for industrial purposes as, for example, the regeneration of shields in sugar-refineries.
- the sea water is subsequently treated in order to increase the percentage of sodium chloride contained therein, by adding salt to the sea water.
- the method and process of thalassotherapy according to the present invention comprises four bathing pools (i.e. pool N°l, pool N°2, pool N°3 and pool N°4) having each one sufficient dimensions to permit to a human being (subject in therapy) to plunge into the liquid contained therein.
- each of said bathing pools may have dimensions sufficient to contain a plurality of people and become an actual swimming pool or thermal basin.
- the first bathing pool (pool N°l) is filled with magnesium chloride in solution, pre-heated at a temperature comprised between 35°C and 39°C.
- Said magnesium chloride in solution has a density comprised between 28° and 30° of Baumie scale (corresponding to about 1.340 Kg/dm' ), which causes a floating of the human body very higher than the normal floating in an untreated sea water or fresh water which, as known, have a density comprised between 8° and 9° of Baumie scale.
- the magnesium chloride in solution increases the antigravitational action which normally has also the sea water at its own low density. Moreover the effect of the high floating of such liquid compound (the magnesium chloride in solution) permits its use for therapeutic purposes of functional rehabilitation.
- the high concentration of magnesium (Mg++) in the liquid compound also determines a certain transdermal absorption of the same compound by the plunged subject, which absorption, as well known, has an antispastic and myorelaxing action; in fact its antagonizes Ca++.
- the magnesium chloride in solution due to its high concentration of magnesium (Mg++) and its myorelaxing action, can be used also in the skeleton-muscle pathology and for help and increasing the general, muscular relaxation, first step in any relaxing training techniques.
- said liquid compound performs a myorelaxing action also in the desmenorrheic syndrome and in the women premestrual tensions.
- the magnesium chloride in solution for the aforementioned properties, is suitable to be used also in the psychophysical preparation to childbirth, because it helps the relaxation of pelvic and perineal musculature; relaxation which can be obtained by means of any technique, which effects are amplified and increased by the plunge in said first bathing pool (pool N°l) containing the magnesium chloride in solution obtained from the sea water.
- the magnesium chloride in solution for its above mentioned properties and for its particular saline concentration, can also be utilised both for topical use in some dermal pathologies (psoriasis) and as dehydrating antiedemigenic action and, therefore, also as antihypertensive agent in massotherapy applications, either pure or as drug vehicle.
- the second bathing pool (pool N°2) is filled with sea water previously added with other integral salt, so as to increase the saline concentration and density (about 18°-20° of Baumie scale), and pre-heated at a temperature comprised between 36°C and 38°C. Also in this case a high floating of the subject in therapy and an increased ionic exchange between the plunged body and the hypersalt water is obtained.
- the hypersalinity of the sea water put into the second bathing pool allows the utilisation of such a water for curative and preventive therapeutic scopes, as dermal pathology (psoriasis), osteo muscle tendinous and joints pathology; this due both to the physical effect of the water (floating) with rehabilitative therapeutic action and to the chemical action of salts absorbed by ionic exchanges, with myorelaxing and decontracturing action.
- said second bathing pool (pool N°2) can also be accomplished the already known technique of childbirth into water, facilitated by the myorelaxing action of said hypersalt water with respect to the water normally used for such purpose, with the advantage to shorten the labour time before childbirth, the expulsive stage and fetus coming out, owing to the floating action.
- the third and fourth bathing pools are filled with sea water previously pre-heated at temperatures comprised between 33°C and 35°C (pool N°3), and respectively between 28°C and 30°C (pool N°3).
- the sequential plunge of the subject in therapy in the four bathing pools for predetermined periods of time (10-20 minutes), starting from pool N°-l and ending to pool N ⁇ 4, permits to increase the already well known positive effects of thalassotherapy on human organism.
- the sea water, treated as described above and contained in the four bathing pools allows and facilitate the exchange between the organism and the liquid, owing to the high concentration of some essential compound as the magnesium and sodium salts.
- the different concentrations permit to obtain different degrees of floating, which can be exploited for rehabilitation purposes in chronic and intense pathology, and also in physiological situations associated to the physical and muscular general preparation.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Improvements in the method and process of thalassotherapy, wherein the sea water, before being used in the therapeutic process, is previously treated both for altering its natural composition and for increasing its temperature. The improved method and process comprises the use of a plurality of thermal bathing pools each containing sea water differently treated. The time of plunge of the subject in therapy into each of the different thermal bathing pools is predetermined as function of the objectives to be pursued.
Description
TITLE: IMPROVEMENTS IN THE METHOD AND PROCESS OF THALASSOTHERAPY
FIELD OF THE INVENTION
The present invention relates to improvements in the method and process of thalassotherapy, wherein the sea water, before being used in the therapeutic process, is previously treated both for altering its natural composition and for increasing its temperature.
BACKGROUND OF THE INVENTION
It is well known, since the antiquity the use of the sea water for therapeutic scopes. It is also known to heat the sea water in order to increase the pleasure to plunge into the thermal bathing pool.
SUMMARY OF THE INVENTION
The improvements in the method and process of thalassotherapy according to the present invention comprises the step to preliminarily trait the sea water, in order to change its natural composition, before putting it into a plurality of thermal bathing pools on which the subject in therapy is suggested to plunge for a predetermined period of time, as function of the objectives to be pursued.
According to a first characteristic of the present invention, the sea water is preliminary treated to substantially remove the sodium chloride, commonly known as "salt", from there and to transform the same sea water in magnesium chloride in solution.
The magnesium chloride in solution is normally obtained as residual liquid compound from the salt-works, in the production of salt starting from the sea water and till now has been substantially used solely for industrial purposes as, for example, the regeneration of shields in sugar-refineries.
According to a second characteristic of the present invention, the sea water is subsequently treated in order to increase the percentage of sodium chloride contained therein, by adding salt to the sea water.
These and other characteristics of the present invention will be described in more detail, by way of example, without reference to any drawing, which are not necessary for the understanding of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
The method and process of thalassotherapy according to the present invention comprises four bathing pools (i.e. pool N°l, pool N°2, pool N°3 and pool N°4) having each one sufficient dimensions to permit to a human being (subject in therapy) to plunge into the liquid contained therein.
It is obvious that each of said bathing pools may have dimensions sufficient to contain a plurality of people and become an actual swimming pool or thermal basin.
The first bathing pool (pool N°l) is filled with magnesium chloride in solution, pre-heated at a temperature comprised between 35°C and 39°C. Said magnesium chloride in solution has a density comprised between 28° and 30° of Baumie scale (corresponding to about 1.340 Kg/dm' ), which causes a floating of the human body very higher than the
normal floating in an untreated sea water or fresh water which, as known, have a density comprised between 8° and 9° of Baumie scale.
In this manner the magnesium chloride in solution increases the antigravitational action which normally has also the sea water at its own low density. Moreover the effect of the high floating of such liquid compound (the magnesium chloride in solution) permits its use for therapeutic purposes of functional rehabilitation. The high concentration of magnesium (Mg++) in the liquid compound also determines a certain transdermal absorption of the same compound by the plunged subject, which absorption, as well known, has an antispastic and myorelaxing action; in fact its antagonizes Ca++.
The magnesium chloride in solution, due to its high concentration of magnesium (Mg++) and its myorelaxing action, can be used also in the skeleton-muscle pathology and for help and increasing the general, muscular relaxation, first step in any relaxing training techniques. In addition to the foregoing, said liquid compound performs a myorelaxing action also in the desmenorrheic syndrome and in the women premestrual tensions. The magnesium chloride in solution, for the aforementioned properties, is suitable to be used also in the psychophysical preparation to childbirth, because it helps the relaxation of pelvic and perineal musculature; relaxation which can be obtained by means of any technique, which effects are amplified and increased by the plunge in said first bathing pool (pool N°l) containing the magnesium chloride in solution obtained from the sea water.
For the same reasons, also any stretching exercise, for
which the reaching of the muscular relaxation must be pursued for psychological and pathological objectives, is facilitated and developed by means of the plunge of the human body into the liquid compound contained into said first bathing pool (pool N°l).
The magnesium chloride in solution, for its above mentioned properties and for its particular saline concentration, can also be utilised both for topical use in some dermal pathologies (psoriasis) and as dehydrating antiedemigenic action and, therefore, also as antihypertensive agent in massotherapy applications, either pure or as drug vehicle.
The second bathing pool (pool N°2) is filled with sea water previously added with other integral salt, so as to increase the saline concentration and density (about 18°-20° of Baumie scale), and pre-heated at a temperature comprised between 36°C and 38°C. Also in this case a high floating of the subject in therapy and an increased ionic exchange between the plunged body and the hypersalt water is obtained. The hypersalinity of the sea water put into the second bathing pool (pool N°2) allows the utilisation of such a water for curative and preventive therapeutic scopes, as dermal pathology (psoriasis), osteo muscle tendinous and joints pathology; this due both to the physical effect of the water (floating) with rehabilitative therapeutic action and to the chemical action of salts absorbed by ionic exchanges, with myorelaxing and decontracturing action. Into said second bathing pool (pool N°2) can also be accomplished the already known technique of childbirth into water, facilitated by the myorelaxing action of said hypersalt water with respect to the water normally used for such purpose, with the advantage to shorten the labour time
before childbirth, the expulsive stage and fetus coming out, owing to the floating action.
The third and fourth bathing pools (pool N°3 and pool N°4) are filled with sea water previously pre-heated at temperatures comprised between 33°C and 35°C (pool N°3), and respectively between 28°C and 30°C (pool N°3).
The sequential plunge of the subject in therapy in the four bathing pools for predetermined periods of time (10-20 minutes), starting from pool N°-l and ending to pool N≤4, permits to increase the already well known positive effects of thalassotherapy on human organism. In fact the sea water, treated as described above and contained in the four bathing pools, allows and facilitate the exchange between the organism and the liquid, owing to the high concentration of some essential compound as the magnesium and sodium salts. The different concentrations permit to obtain different degrees of floating, which can be exploited for rehabilitation purposes in chronic and intense pathology, and also in physiological situations associated to the physical and muscular general preparation.
The different and suitable temperatures of liquids contained in the four bathing pools, associated to the different concentrations of the salts contained therein, allows and favours the ionic and water exchanges with the organism, also exploiting a vasal gymnastics with vasodilating and vasoconstictive action.
It is obvious that various modifications of the above-described method and process of thalassotherapy are possible, within the scope of the invention hereinbefore described.
Claims
1. Method and process of thalassotherapy, wherein the sea water is firstly subjected to a treatment able to alter its composition, characterized in that said treatment comprises the substantial removal of sodium chloride, so as the residual liquid compound is the magnesium chloride in solution.
2. Method and process of thalassotherapy according to claim 1, characterized in that said residual liquid compound has a density comprised between 28° and 30° of Baumie scale (about 1.340 Kg/dm ) .
3. Method and process of thalassotherapy according to any of the preceding claims, comprising a plurality of thermal bathing pools on which the subject in therapy is able to plunge, characterized in that a first of said thermal bathing pools contains said residual liquid compound.
4. Method and process of thalassotherapy according to claim 3, characterized in that a second of said thermal bathing pools contains sea water added with additional integral salt in order to obtain hypersalt sea water having a density comprised between 18° and 20° of Baumie scale.
5. Method and process of thalassotherapy according to claim 3, characterized in that said residual liquid compound is maintained at a temperature comprised between 35°C and 39°C.
6. Method and process of thalassotherapy according to claim 4, characterized in that said hypersalt sea water is maintained at a temperature comprised between 36°C and 38 °C .
7. Method and process of thalassotherapy comprising a plurality of thermal bathing pools and wherein the sea water is firstly subjected to a treatment able to alter its composition, characterized in that a first of said thermal bathing pools is filled with magnesium chloride in solution.
8. Method and process of thalassotherapy according to claim 7, characterized in that said magnesium chloride in solution is obtained as residual liquid compound from the sea water during the treatment of the sea water for the production of sodium chloride.
9. Method and process of thalassotherapy according to claim 7, characterized in that a second of said thermal bathing pools is filled with sea water hypersalt by the addition of sodium chloride.
10. Method and process of thalassotherapy according to claim 3 or 7, characterized in that a third of said thermal bathing pools is filled with sea water maintained at a temperature comprised between 33°C and 35°C.
11. Method and process of thalassotherapy according to claim 3 or 7, characterized in that a fourth of said thermal bathing pools is filled with sea water maintained at a temperature comprised between 28°C and 30°C.
12. Method and process of thalassotherapy according to claim 11, characterized in that the subject in therapy is sequentially plunged, for predetermined periods of time, into said four thermal bathing pools, starting from said first thermal bathing pool and ending with said fourth thermal bathing pool.
13. Use of the magnesium chloride in solution for therapeutic purposes, substantially as described hereinbefore.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU72739/94A AU7273994A (en) | 1993-07-05 | 1994-07-01 | Improvements in the method and process of thalassotherapy |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT93CA000010A ITCA930010A1 (en) | 1993-07-05 | 1993-07-05 | IMPROVEMENTS IN THE THALASSOTHERAPY METHOD AND PROCESS. |
| ITCA93A000010 | 1993-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1995001798A1 true WO1995001798A1 (en) | 1995-01-19 |
Family
ID=11347001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IT1994/000104 WO1995001798A1 (en) | 1993-07-05 | 1994-07-01 | Improvements in the method and process of thalassotherapy |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7273994A (en) |
| IT (1) | ITCA930010A1 (en) |
| WO (1) | WO1995001798A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19731472A1 (en) * | 1997-07-22 | 1999-01-28 | Gerhard Dr Zellner | Spray fluid useful for reducing swelling of nasal mucosa contains hyper-physiological or hyper-osmolar sodium chloride concentration |
| AU2009202493B2 (en) * | 2008-07-02 | 2012-02-02 | Willeford, Kenneth L | Method and composition for the treatment of skin conditions |
-
1993
- 1993-07-05 IT IT93CA000010A patent/ITCA930010A1/en not_active Application Discontinuation
-
1994
- 1994-07-01 WO PCT/IT1994/000104 patent/WO1995001798A1/en active Application Filing
- 1994-07-01 AU AU72739/94A patent/AU7273994A/en not_active Abandoned
Non-Patent Citations (2)
| Title |
|---|
| DIALOG INFORMATION SERVICES, FILE 144 PASCAL, ACCESSION NUMBER 11613070 * |
| N. BAUDRY ET AL.: "Étude comparative du traitement des affections rhumatismales par la crénothérapie et la thalassothérapie", THÈSE POUR LE DIPLOME D'ÉTAT DE DOCTEUR EN PHARMACIE, 30 March 1987 (1987-03-30) * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19731472A1 (en) * | 1997-07-22 | 1999-01-28 | Gerhard Dr Zellner | Spray fluid useful for reducing swelling of nasal mucosa contains hyper-physiological or hyper-osmolar sodium chloride concentration |
| DE19731472C2 (en) * | 1997-07-22 | 2000-05-25 | Gerhard Zellner | Nasal spray liquid |
| AU2009202493B2 (en) * | 2008-07-02 | 2012-02-02 | Willeford, Kenneth L | Method and composition for the treatment of skin conditions |
Also Published As
| Publication number | Publication date |
|---|---|
| ITCA930010A1 (en) | 1995-01-05 |
| ITCA930010A0 (en) | 1993-07-05 |
| AU7273994A (en) | 1995-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tipton et al. | Cold water immersion: kill or cure? | |
| Riyaz et al. | Spa therapy in dermatology | |
| Xu et al. | Effect of a 21-day balneotherapy program on blood cell counts, ponogen levels, and blood biochemical indexes in servicemen in sub-health condition | |
| WO1995001798A1 (en) | Improvements in the method and process of thalassotherapy | |
| RU93050743A (en) | METHOD FOR TREATING DISEASES WITH DAMAGE OF THE BALANCE MOTOR-VEHICLES | |
| ITCA930006U1 (en) | IMPROVEMENTS IN THE THALASSOTHERAPY METHOD AND PROCESS. | |
| Fabiani et al. | Rheumatologic aspects of mineral water | |
| Fenner | Dangerous Australian box jellyfish | |
| RU2170077C2 (en) | Method for treating patients suffering from myocardial ischemia | |
| How et al. | Management of delayed cases of decompression sickness-3 case reports | |
| JPS59220177A (en) | Sports drink | |
| RU2121828C1 (en) | Method for treating arthritis | |
| JP2571537B2 (en) | Bath liquid | |
| Özcelik et al. | Kangal hot spring with fish (kangal fishy health spa) & psoriasis treatment | |
| SU555889A1 (en) | The method of rehabilitation of the human body after prolonged immobility | |
| Yu et al. | Effects of hot spring tourism on human health | |
| EP0265709A3 (en) | A method and composition for the treatment of bathtubs | |
| Buckley | British Spas: Their Waters and Methods of Treatment: An Extract from Lectures Given in the University of London | |
| JP2571536B2 (en) | Bath liquid | |
| RU2003111845A (en) | METHOD FOR TREATING SPINE OSTEOCHONDROSIS IN A SANATORIUM-RESORT OR MEDICINAL PREVENTIVE INSTITUTION | |
| RU2248784C1 (en) | Method for treating the cases of arthritis and arthrosis | |
| SU577028A1 (en) | Method of treating hypotension patients | |
| RU2304955C2 (en) | Method for treating astenic syndrome | |
| RU2157197C1 (en) | Method for carrying out medical rehabilitation of postinsult patients | |
| RU93042323A (en) | METHOD FOR REHABILITATION TREATMENT OF NEUROLOGICAL MANIFESTATIONS OF SPINE OSTEOCHONDROSIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR BY CA CH CN CZ FI HU JP KP KR KZ LK LV MG MN MW NO NZ PL RO RU SD SK UA US UZ VN |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |